Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cuprofen PLUS tablets
1001010J0BMAEAY
|
Cuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Fenbid 300mg Spansules
1001010J0BEAAAB
|
Fenbid (Systemic) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Fenpaed 100mg/5ml oral suspension
1001010J0CXABBH
|
Fenpaed | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Fenpaed 100mg/5ml oral suspension 5ml sachets
1001010J0CXACBM
|
Fenpaed | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Feverfen 100mg/5ml oral suspension
1001010J0CWABBH
|
Feverfen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Flarin Joint & Muscular Pain Relief 200mg capsules
1001010J0DIABAA
|
Flarin | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galpharm Children's Ibuprofen 100mg/5ml oral suspension
1001010J0DFACBH
|
Galpharm (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galpharm Ibuprofen For Children 100mg/5ml susp 5ml sachets
1001010J0DFAABM
|
Galpharm (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galpharm Maximum Strength Ibuprofen 400mg liquid capsules
1001010J0DFABAU
|
Galpharm (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galpharm Migraine Relief 200mg capsules
1001010J0DFADAA
|
Galpharm (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen 100mg/5ml oral suspension
1001010J0CCADBH
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen 200mg tablets
1001010J0CCAAAD
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Cold and Flu 200mg tablets
1001010J0CCABAD
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Long Lasting 200mg capsules
1001010J0CCACBA
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Long Lasting 300mg capsules
1001010J0CCAFAB
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galprofen Migraine Relief 200mg capsules
1001010J0CCAEAA
|
Galprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Hedex Ibuprofen 200mg caplets
1001010J0CPAAAD
|
Hedex ibuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Hedex Ibuprofen 200mg tablets
1001010J0CPABAD
|
Hedex ibuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibucalm Ibuprofen Pain Relief 5% gel
1003020P0BUAAAC
|
Ibucalm (Topical Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuderm 5% gel
1003020P0BTAAAC
|
Ibuderm | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibufem 200mg tablets
1001010J0CHAAAD
|
Ibufem | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibular 200mg tablets
1001010J0DJAAAD
|
Ibular (Ennogen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibular 400mg tablets
1001010J0DJABAE
|
Ibular (Ennogen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuleve 5% Mousse
1003020P0BCAEAF
|
Ibuleve | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuleve 5% spray
1003020P0BCACAD
|
Ibuleve | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.